|
MALARIA
Malaria (Plasmodium vivax)
Malaria (Plasmodium vivax) Probably ~ 10-20% of the world's cases of P. vivax infection occur in Africa, south of the Sahara. In eastern and southern Africa, P. Vivax represents around 10% of malaria cases but in less than 1% of cases in western and central Africa. Please refer to our copy of a PDF file of the entire article published in a 2001 Supplement to the "American Journal of Tropical Medicine and Hygiene" for additional information.
To view a .pdf, you will need the Adobe Reader.
|
Organism
|
Plasmodium vivax |
|
At Risk
|
~70 - 80 million cases annually
|
|
Humans Infected
|
Affects people of all ages but mostly young children
|
|
Disease Outcome
|
|
|
Vaccine Prospects
|
An effective vaccine is not available at this time
|
|
Available Drugs
|
|
|
Drug Resistance
|
Malaria parasites have become resistant & many insecticides are no longer useful
|

[click map for larger image]
The approximate boundaries of the likely distribution of Plasmodium vivax at the maximum extent of its distribution as reached in different parts of the world between the mid-17th century and the early 20th century (light shading) and the approximate boundaries of P. vivax transmission and significant risk of infection in the late 20th century (dark shading). The boundary of malaria transmission on islands in the Western Pacific Ocean is indicated with a dashed line.
Am.J. Trop. Hyg., 64(1, 2)S.2001, pp. 97-106
General Information: Medline, World Health Organization
|